Orthokeratologic correction of progressive myopia in children with a history of retinopathy of prematurity
https://doi.org/10.21516/2072-0076-2026-19-3-9-14
Abstract
Purpose of the study was to assess the effectiveness of orthokeratological lenses (OCL) in the correction of progressive myopia in children with retinopathy of prematurity (ROP) on the basis of long-term (up to 4 years) dynamic follow-up.
Material and methods. The study included 150 children aged 8–12 years (mean 10.2 ± 1.3 years) with ROP and progressive myopia from –0.75 to –8.25 D. In the study group (n = 125), nocturnal OCL (E-System, Boston XO) were used. Children in the control group (n = 25) were prescribed soft contact lenses.
Results. The duration of lens use was 12–48 months (average 32.1 ± 2.4 months). In 60 % of patients in the study group, a slow progression of myopia was observed, i.e., an increase in refraction by 0.25–0.5 D per year; in 30 % of patients, a rapid progression (more than 1 D per year) requiring especially careful monitoring and correction; in 10 % of children, myopia was stable, with an increase of less than 0.25 D per year. The use of OCL in all patients made it possible to achieve visual acuity without correction at the end of follow-up of 0.98 ± 0.06 (baseline 0.09 ± 0.08). The increase in myopic refraction averaged –0.43 ± 0.22 D (2 times lower than in the control group), the axial length of the eye increased by 0.06 ± 0.03 mm.
Conclusion. Orthokeratology demonstrates high efficiency in stabilizing mild and moderate myopia in children with ROP, reducing the need for constant optical correction.
Keywords
About the Authors
V. V. DmitrievRussian Federation
Vladimir V. Dmitriev — ophthalmologist.
15, Elevatornaya St., Moscow, 115404
T. V. Dmitrieva
Russian Federation
Tatyana V. Dmitrieva — master’s degree holder.
80G, Leningradsky Prospect, Moscow, 119261
L. M. Balashova
Russian Federation
Larisa M. Balashova — Dr. of Med. Sci., professor, general director, head of the department of experimental and clinical ophthalmology.
29/14, Prechistenka St., Moscow, 119034
I. A. Minenko
Russian Federation
Inessa A. Minenko — Dr. of Med. Sci., professor of chair of restorative medicine.
8, Bld. 2, Trubetskaya St., Moscow, 119048
References
1. Simchenko A.V., Ulezko E.A., Mankevich N.A., et al. Retinopathy of prematurity: early detection, monitoring, analysis. Maternal and child health protection. 2024; 1 (43): 58–60 (In Russ.).
2. Aksenova I.V. Features of the eyes of a premature child. Russian pediatric ophthalmologist. 2019; 1: 17–21 (In Russ.).
3. Association of Ophthalmologists. Diagnosis, monitoring, and treatment of the active phase of retinopathy of prematurity: clinical guidelines. Moscow, 2024. 31 p. (In Russ.).
4. Katargina L.A. Retinopathy of prematurity: current state of the problem. Russian pediatric ophthalmology. 2022; 1: 5–25 (In Russ.).
5. Tarutta E.P., Verzhanskaia T.Iu. Stabilizing effect of orthokeratology lenses (ten-year followup results). Russian annals of ophthalmology. 2017; 133 (1): 49–54 (In Russ.). https://doi.org/10.17116/oftalma2017133149-54
6. Kulikova I.L., Aleksandrova K.A. Comparative analysis of accommodative function of the eye in children with hypermetropia, amblyopia, and anisometropia after FEMTOLASIK and children receiving conservative treatment. Modern problems of science and education. 2021; 3: 107 (In Russ.). doi: 10.17513/spno.30698
7. Korotaeva N.V., Ippolitova L.I., Volkova E.N. Analysis of risk factors and morbidity in premature infants with very low and extremely low body weight. Scientific and Medical Bulletin of the Central Black Earth Region. 2023; 93: 85–93 (In Russ.).
8. Aldebasi T., Guma M.A., Bashir R. et al. Intravitreal ranibizumab injection for the treatment of retinopathy of prematurity. Medical Principles and Practice. 2019; 28 (6): 526–32. doi: 10.1159/000500310
9. Sidorenko E.E., Nazarenko A.O., Sidorenko E.I., Obrubov S.A. Efficacy of anti-VEGF drug ranibizumab in the treatment of retinopathy of prematurity. Russian pediatric ophthalmology. 2019; 3: 17–21 (In Russ.).
10. Sidorenko E.I., Sidorenko E.E., Obrubov S.A., Levina N.S. Dynamics of intraocular pressure after intravitreal injection of vascular endothelial growth factor inhibitors in retinopathy of prematurity. Russian ophthalmology of children. 2020; 2: 31–6 (In Russ.). https://rdo.su/index.php/rdo/article/view/88
11. Sidorenko E.I., Sidorenko E.E., Obrubov S.A., Nikolaeva G.V., Vaganova Z.M. Screening studies of retinopathy of prematurity and its prospects for ophthalmology. Russian ophthalmology of children. 2020; 4: 42–7 (In Russ.). https://rdo.su/index.php/rdo/article/view/67
12. Hiraoka T. Myopia control with orthokeratology: A review. Eye Contact Lens. 2022 Mar 1; 48 (3): 100–4. doi: 10.1097/ICL.0000000000000867
13. Tarutta E.P., Tarasova N.A., Proskurina O.V., et al. Peripheral defocus of myopic eyes corrected with Perifocal-M glasses, monofocal glasses, and soft contact lenses. Russian ophthalmological journal. 2018; 11 (4): 36–41 (In Russ.). doi: 10.21516/2072-0076-2018-11-4-36-41
Review
For citations:
Dmitriev V.V., Dmitrieva T.V., Balashova L.M., Minenko I.A. Orthokeratologic correction of progressive myopia in children with a history of retinopathy of prematurity. Russian Ophthalmological Journal. 2026;19(3):9-14. (In Russ.) https://doi.org/10.21516/2072-0076-2026-19-3-9-14
JATS XML

























